SSSUN PHARMACEUTICAL IND L
1,688.80INRR
−5.60−0.33%
At close at 10:23 GMT
INR
No trades
SUNPHARMA fundamentals
SUN PHARMACEUTICAL IND L revenue breakdown overview
SUN PHARMACEUTICAL IND L revenue for the last year amounted to 525.78 B INR, the most of which — 477.58 B INR — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 432.79 B INR. The greatest contribution to the revenue figure was made by United States — last year it brought SUN PHARMACEUTICAL IND L 158.86 B INR, and the year before that — 139.70 B INR.
By source
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
0.00
120.00 B
240.00 B
360.00 B
480.00 B
Pharmaceutical
Currency: INR
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Pharmaceutical
323.25 B
331.39 B
384.26 B
432.79 B
477.58 B
By country
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
0.00
120.00 B
240.00 B
360.00 B
480.00 B
United States
India
Emerging Markets
Rest of the World
Currency: INR
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
United States
109.39 B
103.56 B
117.34 B
139.70 B
158.86 B
India
101.86 B
109.50 B
134.44 B
141.62 B
153.97 B
Emerging Markets
61.97 B
64.05 B
72.76 B
85.63 B
92.42 B
Rest of the World
50.03 B
54.28 B
59.73 B
65.83 B
72.35 B